Citation 150979

RODRIGUEZ,RJ: MIRANDA,CL: STEVENS,JF: DEINZER,ML: BUHLER,DR:. (2001). INFLUENCE OF PRENYLATED AND NON-PRENYLATED FLAVONOIDS ON LIVER MICROSOMAL LIPID PEROXIDATION AND OXIDATIVE INJURY IN RAT HEPATOCYTES.. 39(5)

Citation Details

Title	INFLUENCE OF PRENYLATED AND NON-PRENYLATED FLAVONOIDS ON LIVER MICROSOMAL LIPID PEROXIDATION AND OXIDATIVE INJURY IN RAT HEPATOCYTES.
Authors	RODRIGUEZ,RJ: MIRANDA,CL: STEVENS,JF: DEINZER,ML: BUHLER,DR:
Year	2001
Volume	39
Issue	5

Summary

Year: 2001

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONARINGENIN	ACTIVE
2	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONARINGENIN	ACTIVE
3	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONARINGENIN	ACTIVE
4	ANTICYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONARINGENIN	INACTIVE
5	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,DEMETHYL:	ACTIVE
6	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,DEMETHYL:	ACTIVE
7	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,DEMETHYL:	ACTIVE
8	ANTICYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,DEMETHYL:	INACTIVE
9	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL	ACTIVE
10	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL	ACTIVE
11	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL	ACTIVE
12	ANTICYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL	ACTIVE
13	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,5'-PRENYL:	ACTIVE
14	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,5'-PRENYL:	ACTIVE
15	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,5'-PRENYL:	ACTIVE
16	ANTICYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,5'-PRENYL:	ACTIVE
17	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,4'-O-5'-DIPRENYL:	ACTIVE
18	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,4'-O-5'-DIPRENYL:	ACTIVE
19	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,4'-O-5'-DIPRENYL:	ACTIVE
20	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,4'-O-METHYL:	ACTIVE
21	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,4'-O-METHYL:	ACTIVE
22	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,4'-O-METHYL:	ACTIVE
23	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONARINGENIN,3'-GERANYL:	ACTIVE
24	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONARINGENIN,3'-GERANYL:	ACTIVE
25	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONARINGENIN,3'-GERANYL:	ACTIVE
26	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,TETRAHYDRO:	ACTIVE
27	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,TETRAHYDRO:	ACTIVE
28	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,TETRAHYDRO:	ACTIVE
29	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHOHUMOL,TETRAHYDRO:	ACTIVE
30	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOXANTHOHUMOL,DEHYDRO:	ACTIVE
31	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOXANTHOHUMOL,DEHYDRO:	ACTIVE
32	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOXANTHOHUMOL,DEHYDRO:	ACTIVE
33	ANTICYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOXANTHOHUMOL,DEHYDRO:	ACTIVE
34	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOXANTHOHUMOL,DEHYDRO: HYDRATE	ACTIVE
35	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOXANTHOHUMOL,DEHYDRO: HYDRATE	ACTIVE
36	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOXANTHOHUMOL,DEHYDRO: HYDRATE	ACTIVE
37	ANTICYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOXANTHOHUMOL,DEHYDRO: HYDRATE	ACTIVE
38	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	ACTIVE
39	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	ACTIVE
40	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	ACTIVE
41	ANTICYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	ACTIVE
42	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	ACTIVE
43	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	ACTIVE
44	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	ACTIVE
45	ANTICYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	ACTIVE
46	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
47	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
48	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE

Citation 150979

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1